BRIEF-Neurovive redirects research resources from Asian subsidiary to parent company
* Says under agreement, Neurovive Pharmaceutical AB will receive approximately 5 million SEK before transaction costs * Says in addition, Neurovive and its collaboration partner Foundation Asia Pacific LTD. Will reacquire Hong Kong based subsidiary …
News story posted on 2017-01-25T02:34:00